// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
In 2015 and 2016, USP launched a series of “roundtable” events designed to engage industry in dis
Many of the drug ingredients used in generic medicines around the world are produced in China, an
2014 was an exciting year for USP Quality Matters.